OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

ASTRAZENECA PLC DL-,25/  GB0009895292  /

Hannover
4/26/2024  8:05:40 AM Chg. +7.10 Volume Bid8:36:34 PM Ask8:36:34 PM Market Capitalization Dividend Y. P/E Ratio
140.20EUR +5.33% 0
Turnover: 0.00		 -Bid Size: - -Ask Size: - 217.35 bill.EUR - -
TeleTrader 4/25 Europe opens mostly down after corporate earnings
TeleTrader 4/25 AstraZeneca Q1 revenue jumps 19% to $12.7B
GlobeNewswire 3/28 HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Pati...
TeleTrader 3/19 AstraZeneca to acquire Fusion for $2 billion
GlobeNewswire 3/18 AAFA Statement in Response to AstraZeneca Asthma Inhaler Cost Announcement
TeleTrader 3/14 AstraZeneca to acquire Amolyt Pharma for $1.05B
GlobeNewswire 3/14 Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca
GlobeNewswire 2/28 HUTCHMED Reports 2023 Full Year Results and Provides Business Updates
GlobeNewswire 2/26 FibroGen Reports Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire 2/26 FibroGen Regains All Rights to Roxadustat from AstraZeneca in the United States and Other AstraZenec...
GlobeNewswire 2/22 Gracell Biotechnologies Acquisition Completed
GlobeNewswire 2/22 Sodexo and AstraZeneca extend their global partnership for a further 5 years.
GlobeNewswire 2/20 Gracell Biotechnologies Announces Shareholders’ Approval of Merger Agreement
TeleTrader 2/9 Europe mostly lower premarket amid German CPI, earnings
TeleTrader 2/8 Europe closes mostly higher following earnings
TeleTrader 2/8 AstraZeneca sinks almost 7% after missing operating profit estimates
TeleTrader 2/8 AstraZeneca's revenue in Q4 rises 5% to $11.3B
GlobeNewswire 2/5 Yiviva Announces Memorandum of Understanding with AstraZeneca to Develop Platforms, Technologies, an...
GlobeNewswire 2/2 BridgeBio Pharma Shares Positive Results of Single-Arm Phase 3 Study of Acoramidis in Japanese Patie...
GlobeNewswire 1/10 Absci Appoints Professor Sir Mene Pangalos to its Board of Directors
Newsfile Corp 1/9 The World's 30 Best Places to Work for 2023 Revealed
GlobeNewswire 1/3 Use of SGLT2 Inhibitors Continues to Expand for the Treatment of Chronic Kidney Disease, with Eli Li...
TeleTrader 12/27/2023 US opens mostly flat ahead of jobs data
GlobeNewswire 12/27/2023 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GRCL, RYZB, BRBS
TeleTrader 12/26/2023 AstraZeneca to acquire Gracell in $1.2 billion deal